Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.


Updates from The Motley Fool

Latest updates on Bristol-Myers Squibb from Fool.com.


Stock Performance

BMY vs. S&P 500 | 2 Year Performance
View Interactive BMY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bristol-Myers Squibb.
Current Price: $58.77
Prev Close: $58.76
Open: $58.76
Bid: $58.80
Ask: $58.83
Day's Range: $58.54 - $59.40
52wk Range: $56.32 - $77.12
Volume: 7,841,919
Avg Vol 13,257,284
Market Cap: $98.05B
P/E (ttm): 21.06
EPS (ttm): $2.79
Div & Yield: $1.52 (2.6%)

Company Rating

What our community thinks about Bristol-Myers Squibb.
CAPS Rating 4 out of 5
 
1729 Outperform
115 Underperform
CAPS All Stars
 
438 Outperform
17 Underperform

How do you think Bristol-Myers Squibb will perform against the market?



You pick for Bristol-Myers Squibb is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Giovanni Caforio, CEO

88% Approve

Based on 131 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Bristol-Myers Squibb.

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers